{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T10:14:49Z","timestamp":1781259289659,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mixed lineage leukemia 1 (MLL1) is a histone H3 lysine 4 (H3K4) methyltransferase that interacts with WD repeat domain 5 (WDR5) to regulate cell survival, proliferation, and senescence. The role of MLL1 in the pathogenesis of acute kidney injury (AKI) is unknown. In this study, we demonstrate that MLL1, WDR5, and trimethylated H3K4 (H3K4me3) were upregulated in renal tubular cells of cisplatin-induced AKI in mice, along with increased phosphorylation of p53 and decreased expression of E-cadherin. Administration of MM102, a selective MLL1\/WDR5 complex inhibitor, improved renal function and attenuated tubular injury and apoptosis, while repressing MLL1, WDR5, and H3K4me3, dephosphorylating p53 and preserving E-cadherin. In cultured mouse renal proximal tubular cells (RPTCs) exposed to cisplatin, treatment with MM102 or transfection with siRNAs for either MLL1 or WDR5 also inhibited apoptosis and p53 phosphorylation while preserving E-cadherin expression; p53 inhibition with Pifithrin-\u03b1 lowered cisplatin-induced apoptosis without affecting expression of MLL1, WDR5, and H3K4me3. Interestingly, silencing of E-cadherin offset MM102\u2019s cytoprotective effects, but had no effect on p53 phosphorylation. These findings suggest that MLL1\/WDR5 activates p53, which, in turn, represses E-cadherin, leading to apoptosis during cisplatin-induced AKI. Further studies showed that MM102 effectively inhibited cisplatin-triggered DNA damage response (DDR), as indicated by dephosphorylation of ataxia telangiectasia mutated (ATM) and ATM and Rad-3 related (ATR) proteins, dephosphorylation of checkpoint kinase 1 and 2 (Chk1 and Chk2); depression of \u03b3-H2AX; and restrained cell cycle arrest, as evidenced by decreased expression of p21 and phospho-histone H3 at serine 10 in vitro and in vivo. Overall, we identify MLL1 as a novel DDR regulator that drives cisplatin-induced RPTC apoptosis and AKI by modulating the MLL1\/WDR5-\/ATR\/ATM-Chk-p53-E-cadherin axis. Targeting the MLL1\/WDR5 complex may have a therapeutic potential for the treatment of AKI.<\/jats:p>","DOI":"10.1038\/s41419-022-05104-0","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T13:03:46Z","timestamp":1662469426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Histone methyltransferase MLL1 drives renal tubular cell apoptosis by p53-dependent repression of E-cadherin during cisplatin-induced acute kidney injury"],"prefix":"10.1038","volume":"13","author":[{"given":"Chunyun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Bayliss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shougang","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"5104_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.taap.2016.10.022","volume":"313","author":"M Yan","year":"2016","unstructured":"Yan M, Tang C, Ma Z, Huang S, Dong Z. DNA damage response in nephrotoxic and ischemic kidney injury. Toxicol Appl Pharm. 2016;313:104\u20138.","journal-title":"Toxicol Appl Pharm"},{"key":"5104_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/leu.2010.6","volume":"24","author":"LJ Mah","year":"2010","unstructured":"Mah LJ, El-Osta A, Karagiannis TC. gammaH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia. 2010;24:679\u201386.","journal-title":"Leukemia"},{"key":"5104_CR3","doi-asserted-by":"publisher","first-page":"6572","DOI":"10.1074\/jbc.M707568200","volume":"283","author":"N Pabla","year":"2008","unstructured":"Pabla N, Huang S, Mi QS, Daniel R, Dong Z. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem. 2008;283:6572\u201383.","journal-title":"J Biol Chem"},{"key":"5104_CR4","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/sj.ki.5002786","volume":"73","author":"N Pabla","year":"2008","unstructured":"Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 2008;73:994\u20131007.","journal-title":"Kidney Int"},{"key":"5104_CR5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.lfs.2008.08.002","volume":"83","author":"K Tsuruya","year":"2008","unstructured":"Tsuruya K, Yotsueda H, Ikeda H, Taniguchi M, Masutani K, Hayashida H, et al. Involvement of p53-transactivated Puma in cisplatin-induced renal tubular cell death. Life Sci. 2008;83:550\u20136.","journal-title":"Life Sci"},{"key":"5104_CR6","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1681\/ASN.2013080902","volume":"25","author":"D Zhang","year":"2014","unstructured":"Zhang D, Liu Y, Wei Q, Huo Y, Liu K, Liu F, et al. Tubular p53 regulates multiple genes to mediate AKI. J Am Soc Nephrol. 2014;25:2278\u201389.","journal-title":"J Am Soc Nephrol"},{"key":"5104_CR7","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s10495-006-8760-5","volume":"11","author":"J Bodo","year":"2006","unstructured":"Bodo J, Jakubikova J, Chalupa I, Bartosova Z, Horakova K, Floch L, et al. Apoptotic effect of ethyl-4-isothiocyanatobutanoate is associated with DNA damage, proteasomal activity and induction of p53 and p21cip1\/waf1. Apoptosis. 2006;11:1299\u2013310.","journal-title":"Apoptosis"},{"key":"5104_CR8","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s41418-021-00764-5","volume":"28","author":"A Helbling-Leclerc","year":"2021","unstructured":"Helbling-Leclerc A, Garcin C, Rosselli F. Beyond DNA repair and chromosome instability-Fanconi anaemia as a cellular senescence-associated syndrome. Cell Death Differ. 2021;28:1159\u201373.","journal-title":"Cell Death Differ"},{"key":"5104_CR9","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1017\/erm.2020.3","volume":"22","author":"HL Smith","year":"2020","unstructured":"Smith HL, Southgate H, Tweddle DA, Curtin NJ. DNA damage checkpoint kinases in cancer. Expert Rev Mol Med. 2020;22:e2.","journal-title":"Expert Rev Mol Med"},{"key":"5104_CR10","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/onc.2010.486","volume":"30","author":"JC Cheng","year":"2011","unstructured":"Cheng JC, Auersperg N, Leung PC. Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K\/Akt-mediated suppression of E-cadherin. Oncogene. 2011;30:1020\u201331.","journal-title":"Oncogene"},{"key":"5104_CR11","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1038\/onc.2011.117","volume":"30","author":"JC Cheng","year":"2011","unstructured":"Cheng JC, Auersperg N, Leung PC. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells. Oncogene. 2011;30:3930\u201342.","journal-title":"Oncogene"},{"key":"5104_CR12","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/path.3000","volume":"226","author":"ML Taddei","year":"2012","unstructured":"Taddei ML, Giannoni E, Fiaschi T, Chiarugi P. Anoikis: an emerging hallmark in health and diseases. J Pathol. 2012;226:380\u201393.","journal-title":"J Pathol"},{"key":"5104_CR13","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s41374-018-0052-5","volume":"98","author":"L Gao","year":"2018","unstructured":"Gao L, Liu MM, Zang HM, Ma QY, Yang Q, Jiang L, et al. Restoration of E-cadherin by PPBICA protects against cisplatin-induced acute kidney injury by attenuating inflammation and programmed cell death. Lab Invest. 2018;98:911\u201323.","journal-title":"Lab Invest"},{"key":"5104_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1589-y","volume":"10","author":"J Ni","year":"2019","unstructured":"Ni J, Hou X, Wang X, Shi Y, Xu L, Zheng X, et al. 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression. Cell Death Dis. 2019;10:355.","journal-title":"Cell Death Dis"},{"key":"5104_CR15","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1113\/JP275328","volume":"596","author":"M Yulis","year":"2018","unstructured":"Yulis M, Kusters DHM, Nusrat A. Cadherins: cellular adhesive molecules serving as signalling mediators. J Physiol. 2018;596:3883\u201398.","journal-title":"J Physiol"},{"key":"5104_CR16","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nrc2253","volume":"7","author":"AV Krivtsov","year":"2007","unstructured":"Krivtsov AV, Armstrong SA. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer. 2007;7:823\u201333.","journal-title":"Nat Rev Cancer"},{"key":"5104_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02682-5","volume":"19","author":"A Hu","year":"2021","unstructured":"Hu A, Hong F, Li D, Jin Y, Kon L, Xu Z, et al. Long non-coding RNA ROR recruits histone transmethylase MLL1 to up-regulate TIMP3 expression and promote breast cancer progression. J Transl Med. 2021;19:95.","journal-title":"J Transl Med"},{"key":"5104_CR18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/cancers13040739","volume":"13","author":"D Kim","year":"2021","unstructured":"Kim D, Kim Y, Lee BB, Cho EY, Han J, Shim YM, et al. Metformin reduces histone H3K4me3 at the promoter regions of positive cell cycle regulatory genes in lung cancer cells. Cancers. 2021;13:739","journal-title":"Cancers"},{"key":"5104_CR19","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.2147\/OTT.S114370","volume":"9","author":"R Qiang","year":"2016","unstructured":"Qiang R, Cai N, Wang X, Wang L, Cui K, Wang X, et al. MLL1 promotes cervical carcinoma cell tumorigenesis and metastasis through interaction with \u03b2-catenin. Onco Targets Ther. 2016;9:6631\u201340.","journal-title":"Onco Targets Ther"},{"key":"5104_CR20","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.kint.2019.06.021","volume":"96","author":"H Shimoda","year":"2019","unstructured":"Shimoda H, Doi S, Nakashima A, Sasaki K, Doi T, Masaki T. Inhibition of the H3K4 methyltransferase MLL1\/WDR5 complex attenuates renal senescence in ischemia reperfusion mice by reduction of p16(INK4a). Kidney Int. 2019;96:1162\u201375.","journal-title":"Kidney Int"},{"key":"5104_CR21","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1021\/ja306028q","volume":"135","author":"H Karatas","year":"2013","unstructured":"Karatas H, Townsend EC, Cao F, Chen Y, Bernard D, Liu L, et al. High-affinity, small-molecule peptidomimetic inhibitors of MLL1\/WDR5 protein-protein interaction. J Am Chem Soc. 2013;135:669\u201382.","journal-title":"J Am Chem Soc"},{"key":"5104_CR22","doi-asserted-by":"publisher","first-page":"154435","DOI":"10.1016\/j.metabol.2020.154435","volume":"116","author":"PP Hu","year":"2021","unstructured":"Hu PP, Bao JF, Li A. Roles for fibroblast growth factor-23 and \u03b1-Klotho in acute kidney injury. Metabolism. 2021;116:154435.","journal-title":"Metabolism"},{"key":"5104_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58051-1","volume":"10","author":"J Zhu","year":"2020","unstructured":"Zhu J, Singh M, Selivanova G, Peuget S. Pifithrin-\u03b1 alters p53 post-translational modifications pattern and differentially inhibits p53 target genes. Sci Rep. 2020;10:1049.","journal-title":"Sci Rep"},{"key":"5104_CR24","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3727\/096368909X474258","volume":"18","author":"JL Luebke-Wheeler","year":"2009","unstructured":"Luebke-Wheeler JL, Nedredal G, Yee L, Amiot BP, Nyberg SL. E-cadherin protects primary hepatocyte spheroids from cell death by a caspase-independent mechanism. Cell Transpl. 2009;18:1281\u20137.","journal-title":"Cell Transpl"},{"key":"5104_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.etap.2015.04.018","volume":"40","author":"YJ Kim","year":"2015","unstructured":"Kim YJ, Kim TW, Park SR, Kim HT, Ryu SY, Jung JY. Expression of the Mre11-Rad50-Nbs1 complex in cisplatin nephrotoxicity. Environ Toxicol Pharm. 2015;40:12\u20137.","journal-title":"Environ Toxicol Pharm"},{"key":"5104_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.dnarep.2015.04.030","volume":"32","author":"SE Scanlon","year":"2015","unstructured":"Scanlon SE, Glazer PM. Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment. DNA Repair. 2015;32:180\u20139.","journal-title":"DNA Repair"},{"key":"5104_CR27","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/ncb1982","volume":"11","author":"Y Sun","year":"2009","unstructured":"Sun Y, Jiang X, Xu Y, Ayrapetov MK, Moreau LA, Whetstine JR, et al. Histone H3 methylation links DNA damage detection to activation of the tumour suppressor Tip60. Nat Cell Biol. 2009;11:1376\u201382.","journal-title":"Nat Cell Biol"},{"key":"5104_CR28","doi-asserted-by":"publisher","first-page":"13182","DOI":"10.1073\/pnas.0504211102","volume":"102","author":"Y Sun","year":"2005","unstructured":"Sun Y, Jiang X, Chen S, Fernandes N, Price BD. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc Natl Acad Sci USA. 2005;102:13182\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5104_CR29","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1038\/emboj.2009.258","volume":"28","author":"S Tyagi","year":"2009","unstructured":"Tyagi S, Herr W. E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases. EMBO J. 2009;28:3185\u201395.","journal-title":"EMBO J"},{"key":"5104_CR30","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1101\/gad.275453.115","volume":"30","author":"T Kantidakis","year":"2016","unstructured":"Kantidakis T, Saponaro M, Mitter R, Horswell S, Kranz A, Boeing S, et al. Mutation of cancer driver MLL2 results in transcription stress and genome instability. Genes Dev. 2016;30:408\u201320.","journal-title":"Genes Dev"},{"key":"5104_CR31","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1038\/s41374-018-0106-8","volume":"98","author":"Q Wang","year":"2018","unstructured":"Wang Q, Yu M, Ma Y, Zhang X, Zhang H, Li S, et al. PHF20L1 antagonizes SOX2 proteolysis triggered by the MLL1\/WDR5 complexes. Lab Invest. 2018;98:1627\u201341.","journal-title":"Lab Invest"},{"key":"5104_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ccell.2018.06.002","volume":"34","author":"L Fang","year":"2018","unstructured":"Fang L, Teng H, Wang Y, Liao G, Weng L, Li Y, et al. SET1A-mediated mono-methylation at K342 regulates YAP activation by blocking its nuclear export and promotes tumorigenesis. Cancer Cell. 2018;34:103\u201318.","journal-title":"Cancer Cell"},{"key":"5104_CR33","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1124\/jpet.108.139162","volume":"327","author":"M Jiang","year":"2008","unstructured":"Jiang M, Dong Z. Regulation and pathological role of p53 in cisplatin nephrotoxicity. J Pharm Exp Ther. 2008;327:300\u20137.","journal-title":"J Pharm Exp Ther"},{"key":"5104_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1124\/jpet.302.1.8","volume":"302","author":"BS Cummings","year":"2002","unstructured":"Cummings BS, Schnellmann RG. Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. J Pharm Exp Ther. 2002;302:8\u201317.","journal-title":"J Pharm Exp Ther"},{"key":"5104_CR35","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s00204-015-1633-3","volume":"89","author":"S Zhu","year":"2015","unstructured":"Zhu S, Pabla N, Tang C, He L, Dong Z. DNA damage response in cisplatin-induced nephrotoxicity. Arch Toxicol. 2015;89:2197\u2013205.","journal-title":"Arch Toxicol"},{"key":"5104_CR36","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1073\/pnas.0438031100","volume":"100","author":"H Shimodaira","year":"2003","unstructured":"Shimodaira H, Yoshioka-Yamashita A, Kolodner RD, Wang JY. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc Natl Acad Sci USA. 2003;100:2420\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5104_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clim.2008.08.016","volume":"130","author":"HR Jang","year":"2009","unstructured":"Jang HR, Rabb H. The innate immune response in ischemic acute kidney injury. Clin Immunol. 2009;130:41\u201350.","journal-title":"Clin Immunol"},{"key":"5104_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/cas.14691","volume":"112","author":"X Zheng","year":"2021","unstructured":"Zheng X, Pan Y, Chen X, Xia S, Hu Y, Zhou Y, et al. Inactivation of homeodomain-interacting protein kinase 2 promotes oral squamous cell carcinoma metastasis through inhibition of P53-dependent E-cadherin expression. Cancer Sci. 2021;112:117\u201332.","journal-title":"Cancer Sci"},{"key":"5104_CR39","doi-asserted-by":"publisher","first-page":"701175","DOI":"10.3389\/fcell.2021.701175","volume":"9","author":"M Ramirez Moreno","year":"2021","unstructured":"Ramirez Moreno M, Stempor PA, Bulgakova NA. Interactions and feedbacks in E-cadherin transcriptional regulation. Front Cell Dev Biol. 2021;9:701175","journal-title":"Front Cell Dev Biol."},{"key":"5104_CR40","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S0960-9822(99)80454-0","volume":"9","author":"M Ryt\u00f6maa","year":"1999","unstructured":"Ryt\u00f6maa M, Martins LM, Downward J. Involvement of FADD and caspase-8 signalling in detachment-induced apoptosis. Curr Biol. 1999;9:1043\u20136.","journal-title":"Curr Biol"},{"key":"5104_CR41","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nm.2144","volume":"16","author":"L Yang","year":"2010","unstructured":"Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV. Epithelial cell cycle arrest in G2\/M mediates kidney fibrosis after injury. Nat Med. 2010;16:535\u201343.","journal-title":"Nat Med"},{"key":"5104_CR42","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nrneph.2015.3","volume":"11","author":"DA Ferenbach","year":"2015","unstructured":"Ferenbach DA, Bonventre JV. Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat Rev Nephrol. 2015;11:264\u201376.","journal-title":"Nat Rev Nephrol"},{"key":"5104_CR43","first-page":"482","volume":"18","author":"MS Paller","year":"1998","unstructured":"Paller MS. Acute renal failure: controversies, clinical trials, and future directions. Semin Nephrol. 1998;18:482\u20139.","journal-title":"Semin Nephrol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05104-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05104-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05104-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T12:36:16Z","timestamp":1664973376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05104-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["5104"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05104-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental protocols were performed according to the National Institutes of Health Guidelines on the Care and Use of Laboratory Animals and approved by the Lifespan Animal Welfare Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"770"}}